Epidemiology of epithelial ovarian cancer, Best Pract Res Clin Obstet Gynaecol, vol.41, pp.3-14, 2017. ,
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, N Engl J Med, vol.363, pp.943-53, 2010. ,
Oncology meets immunology: the cancer-immunity cycle, Immunity, vol.39, pp.1-10, 2013. ,
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma, Cancer, vol.77, pp.1303-1313, 1996. ,
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer, J Clin Oncol, vol.27, pp.186-92, 2009. ,
Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas, Cancer Res, vol.61, pp.3932-3938, 2001. ,
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer, Br J Cancer, vol.109, pp.2705-2718, 2013. ,
Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer, Hum Pathol, vol.43, pp.1688-94, 2012. ,
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer, Gynecol Oncol, vol.114, pp.105-115, 2009. ,
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proc Natl Acad Sci U S A, vol.102, pp.18538-18581, 2005. ,
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer, N Engl J Med, vol.348, pp.203-216, 2003. ,
Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment, Cell Mol Immunol, vol.12, pp.580-91, 2015. ,
Prognostic significance of CD3+ tumorinfiltrating lymphocytes in ovarian carcinoma, Gynecol Oncol, vol.108, pp.415-435, 2008. ,
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes, Br J Cancer, vol.101, pp.1513-1534, 2009. ,
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer, Journal of translational medicine, vol.11, p.147, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00834422
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss, Mod Pathol, vol.22, pp.393-402, 2009. ,
Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma, PLoS One, vol.8, p.82406, 2013. ,
, Patient inflammatory status and CD4+/CD8+
, intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer, Gynecologic oncology, vol.151, pp.10-17, 2018.
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Med, vol.10, pp.942-951, 2004. ,
Analysis of FoxP3+ Tregulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers, PLoS One, vol.9, p.111757, 2014. ,
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma, Cancer Res, vol.67, pp.8900-8905, 2007. ,
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer, Cancer Immunol Immunother, vol.58, pp.449-59, 2009. ,
Systematic analysis of immune infiltrates in highgrade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors, PLoS One, vol.4, p.6412, 2009. ,
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy, Lancet Oncol, vol.19, pp.40-50, 2018. ,
Ovarian cancer and the immune system, Gynecol Oncol Rep, vol.19, pp.57-65, 2017. ,
Ovarian cancer and the immune system -The role of targeted therapies, Gynecologic oncology, vol.142, pp.349-56, 2016. ,
Prognostic Significance of Neutrophil-to ,
, Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies, Cell Physiol Biochem, vol.41, pp.2411-2419, 2017.
Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer, Cancer Chemother Pharmacol, vol.75, pp.255-62, 2015. ,
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma, The New England journal of medicine, vol.377, pp.1345-56, 2017. ,
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer, Eur J Cancer, vol.109, pp.12-20, 2019. ,
The first-week proliferative response of peripheral blood PD-1(+)CD8(+) T cells predicts the response to anti-PD-1 therapy in solid tumors, Clin Cancer Res, 2019. ,
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab, Cell, vol.171, pp.934-983, 2017. ,
, Safety and Antitumor Activity of Anti-PD, issue.1
Patients With Platinum-Resistant Ovarian Cancer, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.33, pp.4015-4037, 2015. ,
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: Interim results from the phase 2 KEYNOTE-100 study. (Abstract), Journal of Clinical Oncology, 2018. ,
Pembrolizumab in patients (pts) with PD-L1-positive (PD-L1+) advanced ovarian cancer: Updated analysis of KEYNOTE-028. (Abstract), Journal of Clinical Oncology, 2017. ,
The many roles of FAS receptor signaling in the immune system, Immunity, vol.30, pp.180-92, 2009. ,
Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex, Mol Cell Biol, vol.23, pp.1428-1468, 2003. ,
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, The EMBO journal, vol.14, pp.5579-88, 1995. ,
Serum and tissue CD23, IL-15, and FasL in cow's-milk protein-sensitive enteropathy and in coeliac disease, Journal of pediatric gastroenterology and nutrition, vol.54, pp.525-556, 2012. ,
Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis, J Histochem Cytochem, vol.63, pp.931-973, 2015. ,
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors, Nature medicine, vol.20, pp.607-622, 2014. ,
Poissonnier A, Legembre P. Boyden Chamber Assay to Study of Cell Migration Induced by Metalloprotease Cleaved-CD95L, Methods Mol Biol, vol.9, pp.117-140, 2011. ,
Staging classification for cancer of the ovary, fallopian tube, and peritoneum, Int J Gynaecol Obstet, vol.124, pp.1-5, 2014. ,
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research, Adv Anat Pathol, vol.24, pp.235-51, 2017. ,
An application of changepoint methods in studying the effect of age on survival in breast cancer, Computational Statistics & Data Analysis, vol.30, pp.252-70, 1999. ,
Aldehyde dehydrogenase 1 ,
, ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma, Hum Pathol, 2017.
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol.22, pp.1337-1380, 2012. ,
A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer, Gynecol Oncol, vol.145, pp.230-235, 2017. ,
Evolution of the cancer stem cell model, Cell Stem Cell, vol.14, pp.275-91, 2014. ,
Metastatic stem cells: sources, niches, and vital pathways, Cell Stem Cell, vol.14, pp.306-327, 2014. ,
CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice, Immunity, vol.45, pp.209-232, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02378067
Role of MMP-7 in the pathogenesis of systemic lupus erythematosus (SLE), Lupus, vol.26, pp.937-980, 2017. ,
, Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma, Nature, vol.474, pp.609-624, 2011.
Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases, Front Immunol, vol.8, p.316, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01518119
Ovarian cancer tumor infiltrating Tregulatory (T(reg)) cells are associated with a metastatic phenotype, Gynecol Oncol, vol.116, pp.556-62, 2010. ,
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma, Cancer Biol Ther, vol.12, pp.367-77, 2011. ,
Microenvironment tailors nTreg structure and function, Proc Natl Acad Sci, vol.116, pp.6298-307, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02392153
CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer, Cancer research, vol.73, pp.6711-6732, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00873634